Integrated Exercise Program in Opioid Agonist Therapy Clinics
BAReAktiv
Integrated Exercise in Opioid Agonist Therapy Clinics: A Randomised Controlled Trial
1 other identifier
interventional
309
1 country
2
Brief Summary
Background: Drug use is associated with unhealthy lifestyle choices, resulting in adverse social and health consequences. Particular people with opioid dependence have high morbidity and reduced quality of life. A reduction in fitness level for people with substance use disorder reduces the general health and quality of life. Physical activity is recommended as an adjunctive treatment for people with substance use disorder. Due to its positive effects on health, quality of life and substance use. There is minimal evidence from well-controlled randomised trials among people receiving opioid agonist therapy. However, studies indicate that exercise could be promising in opioid agonist therapy. Study design: BAReAktiv is a multicentre randomised controlled trial. The study aims to recruit approximately 225 patients receiving opioid agonist therapy. Intervention: A 16-week group-based exercise intervention with workouts twice a week. The exercise program will consist of endurance and strength training. The intervention will be integrated into outpatient's clinics in Bergen and Stavanger, Norway. Study population: The target group will be patients over 18 years of age with severe opioid use disorder receiving OAT in outpatient clinics. Expected outcome: This study will inform the relative advantages and disadvantages of an integrated exercise program as an adjunctive treatment. Both physical and mental health outcomes are of interest. Further scale-up will be considered if the provided exercise program is safe and effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2022
CompletedFirst Posted
Study publicly available on registry
February 16, 2022
CompletedStudy Start
First participant enrolled
April 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedAugust 8, 2025
August 1, 2025
1.5 years
February 7, 2022
August 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychological distress
The primary outcome is psychological distress assessed with the Norwegian validated translation ten item version of Hopkins Symptom Checklist (SCL-10) in the mid of the intervention period 16 weeks after initiation (12-20). This will be evaluated with mean SCL-10 item score and compared between intervention and control arm.
Mid of the intervention period 16 weeks after initiation
Secondary Outcomes (5)
Physical functioning
Mid of the intervention period 16 weeks after initiation
Physical functioning
Mid of the intervention period 16 weeks after initiation
Fatigue Symptom Scale
Mid of the intervention period 16 weeks after initiation
Biochemical indicator of inflammation
Mid of the intervention period 16 weeks after initiation
Health-related quality of life
Mid of the intervention period 16 weeks after initiation
Study Arms (2)
Exercise intervention
EXPERIMENTALThe intervention is a supervised group-based exercise intervention for 16 weeks, including two outdoor sessions per week. The workout consists of two parts, endurance and a strength training segment. Every workout follows the same structure and lasts approximately 45 minutes. The exercise starts with roughly 15 minutes of endurance warm-up. After the warm-up follows the interval with eight repetitions of 30 seconds uphill, and the participants can freely choose between walking or running. The desired intensity of the intervals is \>13 on Borg-score 20. The session will end with four specific exercises focusing on strength training of large muscle groups, including mm. pectoralis major, rectus abdominis, quadriceps femoris, gluteus maximus and latissimus dorsi. The strength training program follows the same structure as the intervals. Clinical staff, research staff, and people with user experience will supervise the exercise sessions.
Standard
NO INTERVENTIONParticipants randomised to standard treatment will receive regular OAT clinic follow-up without added supplementation.
Interventions
The intervention is a supervised group-based exercise intervention for 16 weeks, including two outdoor sessions per week. The workout consists of two parts, endurance and a strength training segment. Every workout follows the same structure and lasts approximately 45 minutes. The exercise starts with roughly 15 minutes of endurance warm-up. After the warm-up follows the interval with eight repetitions of 30 seconds uphill, and the participants can freely choose between walking or running. The desired intensity of the intervals is \>13 on Borg-score 20. The session will end with four specific exercises focusing on strength training of large muscle groups, including mm. pectoralis major, rectus abdominis, quadriceps femoris, gluteus maximus and latissimus dorsi. The strength training program follows the same structure as the intervals. Clinical staff, research staff, and people with user experience will supervise the exercise sessions.
Eligibility Criteria
You may qualify if:
- Receiving OAT from an included outpatient clinic with follow-up weekly
- Low level of physical activity measured using IPAQ (assessed at screening)
- Confirming interest in participating in physical activity intervention and providing informed consent (criteria specified)
- Giving informed consent
You may not qualify if:
- Not able to participate in the intervention due to physical disabilities or severe mental disorders
- Being imprisoned or in inpatient treatment settings
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Haukeland University Hospitallead
- Helse Stavanger HFcollaborator
- Helse Vestcollaborator
- University of Bergencollaborator
Study Sites (2)
LAR Helse Stavanger HF
Stavanger, Rogaland, 4010, Norway
Department of Addiction Medicine, Haukeland University Hospital
Bergen, Vestland, 5020, Norway
Related Publications (1)
Furulund E, Madebo T, Druckrey-Fiskaaen KT, Vold JH, Nordbotn MH, Dahl E, Dyrstad SM, Lid TG, Fadnes LT; ATLAS4LAR study group. Integrated exercise program in opioid agonist therapy clinics and effect on psychological distress: study protocol for a randomized controlled trial (BAReAktiv). Trials. 2024 Feb 29;25(1):155. doi: 10.1186/s13063-024-07993-2.
PMID: 38424609DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lars T Fadnes, PHD
Haukeland University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Blinding is regarded as difficult and infeasible. Patients will be informed of the follow-up they will receive, but not on other follow-up alternatives that are used or the exact hypotheses for the study. Outcomes assessor will be blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2022
First Posted
February 16, 2022
Study Start
April 7, 2022
Primary Completion
October 1, 2023
Study Completion
March 1, 2025
Last Updated
August 8, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share